| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV | Director | Common Shares | 0 | $0 | $1.63 | Nov 13, 2025 | Direct |
| LAVA Therapeutics NV | Director | Common Shares (Right to Buy) | 33.4K | Feb 13, 2025 | Direct | ||
| Vaxart, Inc. | Director | Stock Option (right to buy) | 15.1K | Jun 16, 2021 | Direct | ||
| Serina Therapeutics, Inc. | Director | Stock Option (right to buy) | 10K | Nov 7, 2025 | Direct | ||
| Elicio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 7.9K | May 19, 2025 | Direct | ||
| LAVA Therapeutics NV | Director | Share Options (Right to Buy) | 0 | Nov 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics NV | Nov 13, 2025 | 2 | $0 | 4 | Nov 17, 2025 | Director |
| SER | Serina Therapeutics, Inc. | Nov 7, 2025 | 1 | $0 | 4 | Nov 10, 2025 | Director |
| ELTX | Elicio Therapeutics, Inc. | May 19, 2025 | 1 | $0 | 4 | May 20, 2025 | Director |
| LVTX | LAVA Therapeutics NV | Feb 13, 2025 | 1 | $0 | 4 | Feb 18, 2025 | Director |
| SER | Serina Therapeutics, Inc. | Jan 14, 2025 | 1 | $0 | 4 | Jan 15, 2025 | Director |
| SER | Serina Therapeutics, Inc. | Jan 14, 2025 | 0 | $0 | 3 | Jan 15, 2025 | Director |
| LVTX | LAVA Therapeutics NV | Jan 1, 2025 | 0 | $0 | 3 | Jan 2, 2025 | Director |
| ELTX | Elicio Therapeutics, Inc. | Nov 21, 2024 | 1 | $0 | 4 | Nov 25, 2024 | Director |
| ELTX | Elicio Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| ELTX | Angion Biomedica Corp. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| VXRT | Vaxart, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |